Cancer Genetics — Merger or Acquisition (August 2015)
12 slides from Cancer Genetics's merger presentation, Aug 11, 2015
Slide 1: CGI enters into agreement in principle to acquire Response Genetics assets
CGI enters into agreement in principle to acquire substantially all of the assets of Response Genetics, Inc. Empowering Personalized Cancer Treatment August 10, 2015
Slide 2: Cautionary Note Regarding Forward Looking Statements
Cautionary Note Regarding Forward Looking Statements: Certain statements contained in this document may be deemed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to anticipated benefits from the proposed transacti
Slide 3: Q1. Why is CGI planning to acquire Response Genetics?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 3 FREQUENTLY ASKED QUESTIONS Q1. Why is CGI planning to acquire Response Genetics, Inc. (“Response”)? A1. Response offers many synergies that further CGI’s mission, including – geographic reach, complement
Slide 4: Q2. Who is Response Genetics, Inc.?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 4 FREQUENTLY ASKED QUESTIONS Q2. Who is Response Genetics, Inc.? A2. Response was founded in 1999 and has an established core business in solid tumor molecular diagnostics, particularly in lung, colorectal
Slide 5: Q4. How will CGI's portfolio change as a result of the acquisition?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 5 FREQUENTLY ASKED QUESTIONS Q4. How will CGI’s portfolio change as a result of the acquisition? Will CGI gain any additional capabilities? A4. The combined company will have one of the most extensive test
Slide 6: Q6. How will CGI's management and reporting structures be affected?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 6 FREQUENTLY ASKED QUESTIONS Q6. How will CGI’s management and reporting structures be affected? A6. CGI does not foresee that the completion of the acquisition will have an immediate effect on the company
Slide 7: Q8. Will this acquisition help expand clinical sales footprint?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 7 FREQUENTLY ASKED QUESTIONS Q8. Will this acquisition help Cancer Genetics expand its clinical sales footprint? A8. Yes. Response’s clinical sales force is particularly strong in the Western, Southeastern
Slide 8: Q11. What products and services does Response offer?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 8 FREQUENTLY ASKED QUESTIONS Q11. What products and services does Response offer and what is the revenue mix? A11. Response has an extensive portfolio or molecular tests that focuses on the diagnosis, prog
Slide 9: Q13. How will the acquisition improve CGI's value proposition?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 9 FREQUENTLY ASKED QUESTIONS Q13. How will the acquisition improve the value proposition of CGI in the market? A13. Cancer Genetics and Response each provide industry-leading expertise in understanding the
Slide 10: Q15. What are the cost and revenue synergy opportunities?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 10 FREQUENTLY ASKED QUESTIONS Q15. What are the cost and revenue synergy opportunities? A15. If and when the transaction closes, CGI anticipates significant revenue synergies for its clinical and biopharma
Slide 11: Q16. What is the Chapter 11 process and Stalking Horse role?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 11 FREQUENTLY ASKED QUESTIONS Q16. What is the Chapter 11 process and what are CGI’s rights and obligations as a Stalking Horse? A16. Chapter 11 of the Bankruptcy Code may be used by a distressed company t
Slide 12: Q18. Will additional information be available on the acquisition?
INVESTOR PRESENTATION | 2015 CANCER GENETICS, INC. | WWW.CANCERGENETICS.COM | @CANCER_GENETICS 12 FREQUENTLY ASKED QUESTIONS Q18. Will there be additional information available on the proposed Response Genetics acquisition? A18. Cancer Genetics will provide additional information on Response, the ca
Cancer Genetics — Merger or Acquisition (August 2015) on 6ix